Is routine pelvic surveillance imaging necessary in patients with Wilms tumor?

Cancer

Volumn 119, Issue 1, 2013, Pages 182-188

  Kaste, Sue C ^a,b   Brady, Samuel L ^a   Yee, Brian ^a   McPherson, Valerie J ^a   Kaufman, Robert A ^a,b   Billups, Catherine A ^a   Daw, Najat C ^c   Pappo, Alberto S ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

computed tomography; pediatrics; surveillance imaging; tumor relapse; Wilms tumor

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHILD; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DOSE CALCULATION; DOSE LENGTH PRODUCT; DOSE RESPONSE; DOSIMETER; DOSIMETRY; EVENT FREE SURVIVAL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; INSTITUTIONAL REVIEW; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METAL OXIDE SEMICONDUCTOR FIELD EFFECT TRANSISTOR DOSIMETER; NEPHROBLASTOMA; ONSET AGE; OVERALL SURVIVAL; PARAMENINGEAL DISORDER; PATIENT SELECTION; PELVIC EXAMINATION; PELVIS RADIOGRAPHY; PELVIS TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; SCHOOL CHILD; SECOND CANCER; SURVIVAL TIME; THORAX RADIOGRAPHY; WILLIAMS BEUREN SYNDROME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PELVIS; RADIATION DOSAGE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WILMS TUMOR; YOUNG ADULT;

EID: 84872803220     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27687     Document Type: Article

References (27)

1. Ries LAG, Smith MA, Gurney JG, et al, eds; National Cancer Institute. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program; 1999.
2. Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the Twenty-First century. J Clin Oncol. 2010; 28: 2625-2634.
3. Biasotti S, Garaventa A, Padovani P, et al. Role of active follow-up for early diagnosis of relapse after elective end of therapies. Pediatr Blood Cancer. 2005; 45: 781-786.
4. Howell L, Mensah A, Brennan B, Makin G,. Detection of recurrence in childhood solid tumors. Cancer. 2005; 103: 1274-1279.
5. Lee AI, Zuckerman DS, Van den Abbeele AD, et al. Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis. Cancer. 2010; 116: 3835-3842.
6. Owens CM, Brisse HJ, Olsen OE, Begent J, Smets AM,. Bilateral disease and new trends in Wilms tumour. Pediatr Radiol. 2008; 38: 30-39.
7. Brenner D, Elliston C, Hall E, Berdon W,. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001; 176: 289-296.
8. Frush DP, Goske MJ, Hernanz-Schulman M,. Computed tomography and radiation exposure. N Engl J Med. 2008; 358: 851-853.
9. Frush DP,. Radiation, CT, and children: the simple answer is.it's complicated. Radiology. 2009; 252: 4-6.
10. Huda W,. Radiation doses and risks in chest computed tomography examinations. Proc Am Thorac Soc. 2007; 4: 316-320.
11. Brody AS, Frush DP, Huda W, Brent RL,. Radiation risk to children from computed tomography. Pediatrics. 2007; 120: 677-682.
12. Green DM, Cotton CA, Malogolowkin M, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2007; 48: 493-499.
13. Malogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008; 50: 236-241.
14. Breslow N, Sharples K, Beckwith JB, et al. Prognostic factors in nonmetastatic, favorable histology Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1991; 68: 2345-2353.
15. Kalapurakal JA, Dome JS, Perlman EJ, et al. Management of Wilms' tumour: current practice and future goals. Lancet Oncol. 2004; 5: 37-46.
16. Huda W, Ogden KM, Khorasani MR,. Converting dose-length product to effective dose at CT. Radiology. 2008; 248: 995-1003.
17. McCollough, C, Cody D, Edyvean S, et al. American Association of Physicists in Medicine (AAPM). The measurement, reporting, and management of radiation dose in CT: report of AAPM Task Group 23 of the Diagnostic Imaging Council CT Committee 2008. No. 96. Available at: http://www.aapm.org. [Access date.]
18. Shrimpton P,. Reference doses for paediatric computed tomography. Radiat Prot Dosimetry. 2000; 90: 249-252.
19. Huda W, Magill D, He W,. CT effective dose per dose length product using ICRP 103 weighting factors. Med Phys. 2011; 38: 1261-1265.
20. International Commission on Radiological Protection (IRCP). The 2007 Recommendations of the International Commission on Radiological Protection: ICRP Publication 103. Amsterdam, the Netherlands: Elsevier; 2007.
21. McCollough C, Schueler B,. Calculation of effective dose. Med Phys. 2000; 27: 828-837.
22. Metzger ML, Dome JS,. Current therapy for Wilms' tumor. Oncologist. 2005; 10: 815-826.
23. Kaste SC,. Oncological imaging: tumor surveillance in children. Pediatr Radiol. 2011; 41 (suppl 2): 505-508.
24. Kan JH, Hwang M, Lowas SR, Hernanz-Schulman M,. Impact of pelvic CT on staging, surveillance, and survival of pediatric patients with Wilms tumor and hepatoblastoma. AJR Am J Roentgenol. 2011; 196: W515-W518.
25. Shamberger RC, Guthrie KA, Ritchey ML, et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Ann Surg. 1999; 229: 292-297.
26. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007; 168: 1-64.
27. Preston DL, Cullings H, Suyama A, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst. 2008; 100: 428-436.